Development of Receptor-Targeted Imaging Agents: Integrated Gallium Complexes and Conjugated Cyclopentadienyl Tricarbonyl Rhenium and Technetium Complexes

As the preferred radionuclide for use in Single Photon Emission Computed Tomography (SPECT) imaging is 99mTc, the development of 99mTc-labeled phenyl-tropane analogs with high affinity for the dopamine transporter (DAT) would provide a useful tool for imaging disorders in this transporter system, such as clinical diagnosis of Parkinson's disease. The Direct Double Ligand Transfer (DLT) reaction was developed and utilized in the preparation of several cyclopentadienyltricarbonyl rhenium phenyl-tropanes. N-[4-Oxo-4-cyclopentadienyltricarbonyl rhenium butyl]-2beta-carbomethoxy-[3beta-(4-iodophenyl)] tropane was tested for affinity to the dopamine transporter in rat brain tissue homogenate as a surrogate to the radiolabeled congener. The computed DAT affinity of the rhenium compound was 5.95 +/- 0.93 nM. Regional cerebral uptake and distribution of the technetium-99m congener was evaluated in vivo in mouse brain. At 60 and 90 min after i.v. injection of the technetium compound, the mouse striatum/cerebellum radioactivity ratio was 2.0 and 2.3, and was reduced to unity in presence of beta-CIT at 60 min. The findings show for the first time that a cyclopentadienyltricarbonyltechnetium complex can penetrate mammalian brain tissue and differentially label DAT-rich corpus striatum.

Name thesis:degree_name

Ph.D.

Level thesis:degree_level

Dissertation

Discipline thesis:degree_discipline

Chemistry

Grantor

University of Illinois at Urbana-Champaign

Year dc:date

2015

Author dc:creator

• Cesati, Richard Raoul, III

Contributors dc:contributor

• Katzenellenbogen, John A.

• Chemistry, Pharmaceutical

Language dc:language

eng

Identifier

(MiAaPQ)AAI3017006

OAI identifier oai:identifier

oai:www.ideals.illinois.edu:2142/84022